These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23185801)

  • 1. Seasonal variation in breast cancer incidence. Circumstantial or default event?
    Markopoulos C; Mantas D; Kouskos E; Antonopoulou Z
    Eur J Gynaecol Oncol; 2012; 33(5):521-3. PubMed ID: 23185801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Birth seasonality of breast cancer patients and its variation according to menopausal status and histologic type in Japan.
    Nakao H
    Eur J Cancer Clin Oncol; 1986 Sep; 22(9):1105-10. PubMed ID: 3780816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonal variation in breast cancer diagnosis in Singapore.
    Gao F; Machin D; Khoo KS; Ng EH
    Br J Cancer; 2001 May; 84(9):1185-7. PubMed ID: 11336468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seasonality and breast cancer.
    Kirkham N; Machin D; Cotton DW; Pike JM
    Eur J Surg Oncol; 1985 Jun; 11(2):143-6. PubMed ID: 4007171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global breast cancer seasonality.
    Oh EY; Ansell C; Nawaz H; Yang CH; Wood PA; Hrushesky WJ
    Breast Cancer Res Treat; 2010 Aug; 123(1):233-43. PubMed ID: 20130986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A seasonal variation in breast cancer.
    McIntyre H; Blue J; Harman J
    N Z Med J; 2002 Jul; 115(1157):U45. PubMed ID: 12362194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
    Glass AG; Lacey JV; Carreon JD; Hoover RN
    J Natl Cancer Inst; 2007 Aug; 99(15):1152-61. PubMed ID: 17652280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms.
    Kravchenko J; Akushevich I; Seewaldt VL; Abernethy AP; Lyerly HK
    Breast Cancer Res Treat; 2011 Jul; 128(2):483-93. PubMed ID: 21225455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of breast cancer in Indonesia and Malaysia--a clinico-pathological study between Dharmais Cancer Centre Jakarta and University Malaya Medical Centre, Kuala Lumpur.
    Ng CH; Pathy NB; Taib NA; Teh YC; Mun KS; Amiruddin A; Evlina S; Rhodes A; Yip CH
    Asian Pac J Cancer Prev; 2011; 12(11):2943-6. PubMed ID: 22393968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for breast cancer according to estrogen and progesterone receptor status.
    Colditz GA; Rosner BA; Chen WY; Holmes MD; Hankinson SE
    J Natl Cancer Inst; 2004 Feb; 96(3):218-28. PubMed ID: 14759989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Pathological Characteristics of Triple Positive Breast Cancer among Iraqi Patients.
    Alwan NAS; Mualla FH; Al Naqash M; Kathum S; Tawfiq FN; Nadhir S
    Gulf J Oncolog; 2017 Sep; 1(25):51-60. PubMed ID: 29019331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women.
    Jemal A; Ward E; Thun MJ
    Breast Cancer Res; 2007; 9(3):R28. PubMed ID: 17477859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid receptor status and its clinicopathological correlation in post-menopausal breast cancer patients of Kumaon region of Uttarakhand.
    Shahi KS; Bhandari G; Singh A
    J Cancer Res Ther; 2011; 7(1):19-22. PubMed ID: 21546737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study.
    Chollet-Hinton L; Anders CK; Tse CK; Bell MB; Yang YC; Carey LA; Olshan AF; Troester MA
    Breast Cancer Res; 2016 Aug; 18(1):79. PubMed ID: 27492244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Seasonal variation of mean birth weight and births in Nagano Prefecture].
    Matsuda S; Doi T; Sone T; Kahyo H
    Nihon Eiseigaku Zasshi; 1992 Jun; 47(2):609-17. PubMed ID: 1513054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The shape of age-incidence curves of female breast cancer by hormone-receptor status.
    Yasui Y; Potter JD
    Cancer Causes Control; 1999 Oct; 10(5):431-7. PubMed ID: 10530614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of prognostic factors in premenopausal women with breast cancer.
    Finek J; Holubec L; Topolcan O; Elgrova L; Skalova A; Pecen L
    Anticancer Res; 2007; 27(4A):1893-6. PubMed ID: 17649790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor characteristics and metabolic quantification in carcinoma breast: An institutional experience.
    Dubey IP; Jain A; Chauhan MS; Kumar R; Agarwal S; Kishore B; Vishnoi MG; Paliwal D; John AR; Kumar N; Sharma A; Pandit AG
    Indian J Cancer; 2017; 54(1):333-339. PubMed ID: 29199717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of changes in biologic markers ER, PR, HER 2 and Ki-67 index in breast cancer with administration of neoadjuvant dose dense doxorubicin, cyclophosphamide followed by paclitaxel chemotherapy.
    Dede DS; Gumuskaya B; Guler G; Onat D; Altundag K; Ozisik Y
    J BUON; 2013; 18(2):366-71. PubMed ID: 23818347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.